Health Care & Life Sciences » Pharmaceuticals | Consun Pharmaceutical Group Ltd.

Consun Pharmaceutical Group Ltd. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
721
920
1,025
1,430
1,914
2,184
Cost of Goods Sold (COGS) incl. D&A
151
200
198
365
498
544
Gross Income
571
720
827
1,064
1,416
1,640
SG&A Expense
323
434
471
603
811
874
EBIT
248
285
356
462
605
766
Unusual Expense
-
1
-
-
-
-
Non Operating Income/Expense
1
11
5
-
37
16
Interest Expense
-
-
1
2
17
33
Pretax Income
266
332
394
467
628
730
Income Tax
73
67
80
98
142
141
Equity in Affiliates
-
-
6
5
-
-
Consolidated Net Income
193
266
308
373
486
589
Net Income
193
266
308
359
457
551
Net Income After Extraordinaries
193
266
308
359
457
551
Net Income Available to Common
193
266
308
359
457
551
EPS (Basic)
0.25
0.26
0.31
0.37
0.53
0.64
Basic Shares Outstanding
759
999
982
960
861
855
EPS (Diluted)
0.25
0.27
0.31
0.37
0.53
0.63
Diluted Shares Outstanding
759
999
982
960
867
878
EBITDA
264
305
379
507
678
846
Non-Operating Interest Income
5
36
34
4
4
13
Minority Interest Expense
-
-
-
14
29
38

About Consun Pharmaceutical Group

View Profile
Address
71 Dong Peng Avenue, Eastern Section
Guangzhou Guangdong 510760
China
Employees -
Website http://www.chinaconsun.com
Updated 07/08/2019
Consun Pharmaceutical Group Ltd. is an investment holding company, which engages in the manufacturing and sales of pharmaceutical products. It operates through Consun Pharmaceutical and Yulin Pharmaceutical segments. The Consun Pharmaceutical segment manufactures and sells modern Chinese medicines and medical contrast medium.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.